[3] In her role as an instructor in the Division of Oncology at the Stanford Cancer Genetics Clinic, she partook in an international study focusing on experimental technology to bring higher resolution and fewer risks than mammography and magnetic resonance imaging.

[8] The next year, she was appointed director of Stanford Women's Clinical Cancer Genetics Program and sat on the Advisory Committee for the California Health Care Foundation.

[9] This resulted in the development of an online tool that helps people with BRCA mutations make preventive care decisions.

[10] In 2014, she conducted a study with Scarlett Gomez which found that breast cancer patients who undergo bilateral mastectomy are not guaranteed better survival rates.

[14] In 2024, Kurian and colleague Jennifer Caswell-Jin were awarded the SCI Equity Impact Research Grant Challenge Award for their contributions to cancer research and treatment, specifically their project, "Cascade testing for genetic cancer risk and follow-up care in rural Californian communities.